Sign Up to like & get
recommendations!
0
Published in 2021 at "Drug discovery today"
DOI: 10.1016/j.drudis.2021.07.017
Abstract: Despite the unprecedented unmet need to discover new antibiotics, only a few molecules have been registered for clinical use. This shortage is primarily based on the scientific failure in the postgenomic era of drug discovery.…
read more here.
Keywords:
new antibiotics;
drug;
drug discovery;
past failures ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Journal of Controlled Release"
DOI: 10.1016/j.jconrel.2020.11.057
Abstract: COVID-19, the disease caused by infection with SARS-CoV-2, requires urgent development of therapeutic interventions. Due to their safety, specificity, and potential for rapid advancement into the clinic, monoclonal antibodies (mAbs) represent a highly promising class…
read more here.
Keywords:
challenges monoclonal;
antibody therapies;
learning past;
failures challenges ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Journal of Financial Economics"
DOI: 10.1016/j.jfineco.2020.06.021
Abstract: Abstract We analyze how public information on past entrepreneurial failure affects entrepreneurs’ ability to borrow and start new ventures. We exploit a policy shock from 2013 in France, which eliminated a widely used means of…
read more here.
Keywords:
failures natural;
entrepreneurship information;
information past;
past failures ... See more keywords